Larvol Delta - NIH-grants-144M-to-Cancer-Targeted-Technology-to-Support-the-Ongoing-Prostate-Cancer-Clinical-Trial-of-a-Promising-New-Radiotherapeutic-CTT1403

CTT1403 - Cancer Targeted Tech

https://www.businesswire.com/news/home/20200807005027/en/NIH-grants-1.44M-Cancer-Targeted-Technology-Support

Aug 7, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next